Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflunomide for polymyalgia rheumatica
NL-OMON21927Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in polymyalgia rheumatica (PMR) comparing Leflunomide + glucocorticoids with Placebo + glucocorticoids (2 arms). Primary endpoint: PMR relapse. Planned start Jun 2018; status: not yet recruiting.
02
Drugs
leflunomide
03
Conditions
polymyalgia rheumatica (PMR)
Beyond the preview
Go deeper on NL-OMON21927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21927.